Clinical Trial Detail

NCT ID NCT01967810
Title ANG1005 in Patients With Recurrent High-Grade Glioma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Angiochem Inc
Indications

brain glioma

Therapies

Bevacizumab

Paclitaxel Trevatide

Age Groups: adult

No variant requirements are available.